发明名称 4-(PYRIDIN-4-YL)-1H-(1, 3, 5)TRIAZIN-2-ONE DERIVATIVES AS GSK3-BETA INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES.
摘要 <p>A triazinone derivative represented by formula (I) wherein: Z represents a bond, a carbonyl group, a methylene group optionally substituted by one or two groups chosen from a C1-6 alkyl group, a hydroxyl group, a Ci-β alkoxy group; R1 represents a 4-pyridine ring; R2 represents a hydrogen atom, a C1-6 alkyl; R3 represents a hydrogen atom, a C1-6 alkyl group; R2 and R3 may form together a 6 membered cycle with the nitrogens caring R2 and R3 optionally substituted; R4 represents: a phenyl ring, being optionally substituted; n represents 0 to 2; in form of a free base or of an addition salt with an acid. The compounds of the present invention have GSK3β inhibitory activity and are useful as an active ingredient of a medicament for preventive and/or therapeutic treatment of diseases caused by abnormal activity of GSK3β and more particularly of neurodegenerative diseases.</p>
申请公布号 MX2010014235(A) 申请公布日期 2011.06.24
申请号 MX20100014235 申请日期 2009.06.25
申请人 MITSUBISHI TANABE PHARMA CORPORATION 发明人 MOURAD SAADY;PHILIPPE YAICHE;ALISTAIR LOCHEAD
分类号 C07D401/04;A61K31/53;A61P3/10;A61P25/28;A61P33/06;A61P35/00;C07D487/04 主分类号 C07D401/04
代理机构 代理人
主权项
地址